Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome

Pathology International

Volumn 48, Issue 12, 1998, Pages 934-943

  Ohshima, Koichi ^a   Suzumiya, Junji ^a   Sugihara, Midori ^a   Nagafuchi, Seiho ^b   Ohga, Shouichi ^c   Kikuchi, Masahiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Chronic active Epstein Barr virus; Cytokine; Hemophagocytic syndrome; Lymphoproliferative disorder

Indexed keywords

CD8 ANTIGEN; LYMPHOKINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENOTYPE; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

EID: 0032420897     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03864.x     Document Type: Article

References (35)

1. Isaacs R. Chronic infectious mononucleosis. Blood 1948; 3: 858-861.
2. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexpected illness: Elevated anti-early antigen antibodies. Ann. Intern. Med. 1985; 102: 1-7.
3. Rickinson AB. Chronic, symptomatic Epstein-Barr virus infection. Immunol. Today 1986; 7: 13-14.
4. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 32: 502-506.
5. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB et al. AIDS-related lymphomas: Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol. 1991; 138: 149-163.
6. Ott G, Ott M, Feller AC, Seidl S, Muller-Hermelink HK. Prevalence of Epstein-Barr virus DNA in different T cell lymphoma entities in European population. Int. J. Cancer 1992; 51: 562-567.
7. Kawa-Ha K, Ishihara S, Ninomiya T et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest. 1989; 84: 51-55.
8. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr. 1995; 84: 1271-1275.
9. Bayliss GJ, Wolf H. Epstein-Barr virus-induced cell fusion. Nature 1980; 287: 164-165.
10. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Pathol. 1994; 144: 1219-1225.
11. Simrell CR, Margolick JB, Crabtree GR, Cossman J, Fauci AS, Jaffe ES. Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesion (AIL) and malignant lymphoma arising in AIL. Blood 1985; 65: 1469-1476.
12. Ohshima K, Fujisaki T, Nagafuchi S, Niho Y, Kobari S, Kikuchi M. Malignant histiocytosis derived from a common histiocyte clone in a patient with chronic Epstein-Barr virus infection. Leuk. Lymphoma 1995; 17: 355-360.
13. Nagafuchi S, Ishibashi H, Anzai K et al. Budd-Chiari syndrome and Epstein-Barr virus (EBV) associated plasmacytoma in a patient with chronic active EBV infection. Clin. Invest. 1994; 72: 883-886.
14. Ohshima K, Kobari S, Kuroiwa S et al. Heterogeneity of systemic extra-nodal Epstein-Barr virus-associated lymphohistiocytic tumor: Ten autopsy cases of human immunodeficiency virus-negative Japanese. Pathol. Res. Pract. 1997; 193: 257-265.
15. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J. Exp. Med. 1989; 169: 2191-2198.
16. Boyle MJ, Vasak E, Tschuchinigg M et al. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: Association between B-type and immunocompromise. Blood 1993; 81: 468-474.
17. Shibata D, Hansmann ML, Weiss LM, Nathwani BN. Epstein-Barr virus infections and Hodgkin's disease: A study of fixed tissues using the polymerase chain reaction. Hum. Pathol. 1991; 22: 1262-1267.
18. Weiss LM, Jaffe ES, Liu XF, Chan YY, Shibata D, Medeiros J. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angloimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79: 1789-1795.
19. Kikuta H, Taguchi Y, Tomizawa K et al. Epstein-Barr virus genome-positive T cell lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 455-457.
20. Jones JF, Shurin S, Abramowsky C et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N. Engl. J. Med. 1988; 318: 733-741.
21. Pallesen G, Hamilton-Dutoit SJ, Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: Two new developments in the EBV field. Adv. Cancer Res. 1993; 62: 179-239.
22. Purtilo DT, Strobach RS, Okano M, Davis JR. Biology of disease: Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Invest. 1992; 67: 5-23.
23. Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 1988; 331: 719-721.
24. Fujieda M, Wakiguchi H, Hisakawa H, Kubota H, Kurashige T. Defective activity of Estein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatr. Jpn. 1933; 35: 394-399.
25. Gershwin ME, Steinberg AD. Loss of suppressor function as a cause of lymphoid malignancy. Lancet 1973; 2: 1174-1176.
26. Favara BE. Hemophagocytic lymphohistiocytosis: A hemophagocytic syndrome. Semin. Diagn. Pathol. 1992; 9: 63-74.
27. Ohshima K, Shimazaki K, Sugihara M et al. Clinicopathological findings of virus-associated hemophagocytic syndrome (VANS) in bone marrow: Epstein-Barr virus infected T cells. Am. J. Hematol. 1998 (in press).
28. Fujiwara F, Hibi S, Imshuku S. Hypercytokinemia in hemophagocytic syndrome. Am. J. Pediatr. Hematol. Oncol. 1993; 15: 92-98.
29. Ohga S, Matsuzaki A, Nishizaki M et al. Inflammatory cytokines in virus-associated hemophagocytic syndrome: Interferon-gamma as a sensitive indicator of disease activity. Am. J. Pediatr. Hematol. Oncol. 1993; 15: 291-298.
30. Grunfeld C, Palladino Jr MA. Tumor necrosis factor: Immunologic, antitumor, metabolic, and cardiovascular activities. Adv. Intern. Med. 1990; 35: 45-72.
31. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 1993; 72: 2019-2027.
32. Falini B, Pileri S, Solas ID et al. Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 1990; 75: 434-444.
33. Delecluse HJ, Raphael M, Magaud JP. Variable morphology of human immunodeficiency-associated lymphomas with c-myc rearrangements: The French Study Group of Pathology for human immunodeficiency virus-associated tumors. Blood 1993; 82: 552-563.
34. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am. J. Hematol. 1997; 54: 276-281.
35. Yatabe Y, Mori N, Oka K et al. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. Arch. Pathol. Lab. Med. 1995; 119: 409-417.